From May 1, the oral contraceptive Slinda (drospirenone) will be listed on the Pharmaceutical Benefits Scheme (PBS). This ...

Oral contraceptive pills (OCPs) are the most commonly used contraceptive measure, owing to their effectiveness and practicability. Women in this region were more familiar with oral ...

The Australian government has announced it will develop an oral contraceptive pill, which is currently accessible on the ...

Contraceptive Pill Users Less Likely to Report Depression Nov. 1, 2023 — A new study has shown that women who are taking the oral contraceptive pill are less likely to report depression.

An experimental hormone-free male contraceptive pill, developed by YourChoice Therapeutics, is showing promise in early human trials. The pill, which interferes with vitamin A signaling necessary for ...

Scientists identified molecular targets of polycystic ovarian syndrome in rodents and humans, paving the way for improved ...

For years, the responsibility of contraception has predominantly fallen on women, with options ranging from pills to patches ...

After decades of attempts to develop a male contraceptive pill, a new study suggests it could be a big step closer to reality. A contraceptive pill for men is on the horizon after early human trials ...

Experts emphasize the importance of informed contraceptive choices, considering both physical and mental health effects for ...

YourChoice Therapeutics, Inc., pioneering hormone-free family planning products, announced today that Communications Medicine, a Nature Portfolio journal, has published a peer-reviewed paper on the ...